Eberhardt Grube

Q: What Schools Are Affiliated With Eberhardt Grube

Eberhardt Grube is affiliated with the following schools: University of Milan, University of Cologne, University of Oxford, Hannover Medical School, Stanford University, University of São Paulo, Columbia University, Duke University, University of Bonn

Eberhardt Grube's AcademicInfluence.com Rankings

Eberhardt Grube

Engineering

#6249

World Rank

#7565

Historical Rank

Biomedical Engineering

#539

World Rank

#549

Historical Rank

engineering Degrees

Eberhardt Grube

Philosophy

#8528

World Rank

#11933

Historical Rank

Logic

#5560

World Rank

#6967

Historical Rank

philosophy Degrees

Download Badge

Engineering
Philosophy

Eberhardt Grube's Degrees

PhD Biomedical Engineering University of California, Berkeley
Doctorate Medicine University of California, San Francisco

Why Is Eberhardt Grube Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Eberhardt Grube's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. (2005) (2484)
Surgical or Transcatheter Aortic‐Valve Replacement in Intermediate‐Risk Patients (2017) (1992)
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. (2007) (1694)
Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for Coronary Artery Lesions (2003) (1093)
TAXUS I: Six- and Twelve-Month Results From a Randomized, Double-Blind Trial on a Slow-Release Paclitaxel-Eluting Stent for De Novo Coronary Lesions (2003) (975)
Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. (2007) (960)
Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. (2010) (782)
Safety of Transesophageal Echocardiography: A Multicenter Survey of 10,419 Examinations (1991) (745)
Percutaneous Implantation of the CoreValve Self-Expanding Valve Prosthesis in High-Risk Patients With Aortic Valve Disease: The Siegburg First-in-Man Study (2006) (703)
Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. (2008) (688)
Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. (2011) (659)
Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I. (2005) (558)
Randomized Study of the Crush Technique Versus Provisional Side-Branch Stenting in True Coronary Bifurcations: The CACTUS (Coronary Bifurcations: Application of the Crushing Technique Using Sirolimus-Eluting Stents) Study (2009) (506)
Incidence and Predictors of Drug-Eluting Stent Thrombosis During and After Discontinuation of Thienopyridine Treatment (2007) (463)
Percutaneous Recanalization of Chronically Occluded Coronary Arteries: A Consensus Document Part II (2005) (411)
Aortic regurgitation index defines severity of peri-prosthetic regurgitation and predicts outcome in patients after transcatheter aortic valve implantation. (2012) (368)
TAXUS III Trial: In-Stent Restenosis Treated With Stent-Based Delivery of Paclitaxel Incorporated in a Slow-Release Polymer Formulation (2003) (356)
Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. (2007) (355)
Clinical Efficacy of Polymer-Based Paclitaxel-Eluting Stents in the Treatment of Complex, Long Coronary Artery Lesions From a Multicenter, Randomized Trial: Support for the Use of Drug-Eluting Stents in Contemporary Clinical Practice (2005) (349)
A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial. (2005) (314)
Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction. (2002) (307)
Progress and Current Status of Percutaneous Aortic Valve Replacement: Results of Three Device Generations of the CoreValve Revalving System (2008) (293)
Transcatheter aortic valve replacement in bicuspid aortic valve disease. (2014) (280)
Correlation of Device landing zone calcification and acute procedural success in patients undergoing transcatheter aortic valve implantations with the self-expanding CoreValve prosthesis. (2010) (263)
First report on a human percutaneous transluminal implantation of a self‐expanding valve prosthesis for interventional treatment of aortic valve stenosis (2005) (260)
Percutaneous aortic valve replacement for severe aortic regurgitation in degenerated bioprosthesis: The first valve in valve procedure using the corevalve revalving system (2007) (232)
2-year follow-up of patients undergoing transcatheter aortic valve implantation using a self-expanding valve prosthesis. (2011) (218)
Six- and Twelve-Month Results From First Human Experience Using Everolimus-Eluting Stents With Bioabsorbable Polymer (2004) (216)
Feasibility of transcatheter aortic valve implantation without balloon pre-dilation: a pilot study. (2011) (201)
Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantation. (2012) (200)
Evaluation and management of paravalvular aortic regurgitation after transcatheter aortic valve replacement. (2013) (189)
Correlation of Peripheral-Blood Gene Expression With the Extent of Coronary Artery Stenosis (2008) (187)
Offsetting Impact of Thrombosis and Restenosis on the Occurrence of Death and Myocardial Infarction After Paclitaxel-Eluting and Bare Metal Stent Implantation (2007) (186)
Prevention of Distal Embolization During Coronary Angioplasty in Saphenous Vein Grafts and Native Vessels Using Porous Filter Protection (2001) (186)
Emergency Polytetrafluoroethylene-Covered Stent Implantation to Treat Coronary Ruptures (2000) (185)
Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials. (2009) (177)
Results of the Jostent coronary stent graft implantation in various clinical settings: Procedural and follow‐up results (2002) (170)
Prospective multicenter evaluation of the direct flow medical transcatheter aortic valve. (2014) (169)
A Bicuspid Aortic Valve Imaging Classification for the TAVR Era. (2016) (162)
Incomplete Stent Apposition After Implantation of Paclitaxel-Eluting Stents or Bare Metal Stents: Insights From the Randomized TAXUS II Trial (2005) (158)
First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation. (2012) (149)
“Device landing zone” calcification, assessed by MSCT, as a predictive factor for pacemaker implantation after TAVI (2010) (149)
Incidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent: a TAXUS II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 years. (2007) (140)
Transaortic transcatheter aortic valve implantation: A novel approach for the truly “no‐access option” patients (2010) (139)
Clinical Outcomes With a Repositionable Self-Expanding Transcatheter Aortic Valve Prosthesis: The International FORWARD Study. (2017) (131)
Percutaneous recanalization of chronically occluded coronary arteries: Procedural techniques, devices, and results (2005) (129)
Systemic inflammatory response syndrome predicts increased mortality in patients after transcatheter aortic valve implantation. (2012) (124)
One-year results of a durable polymer everolimus-eluting stent in de novo coronary narrowings (The SPIRIT FIRST Trial). (2005) (121)
Transcatheter aortic valve implantation: predictors of procedural success--the Siegburg-Bern experience. (2010) (119)
Management of arterial puncture site after catheterization procedures: evaluating a suture-mediated closure device. (1999) (118)
Chronic Arterial Responses to Polymer-Controlled Paclitaxel-Eluting Stents: Comparison With Bare Metal Stents by Serial Intravascular Ultrasound Analyses: Data From the Randomized TAXUS-II Trial (2004) (118)
Final 5-Year Results of the TAXUS II Trial: A Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for De Novo Coronary Artery Lesions (2009) (117)
A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein grafts. (2003) (116)
Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials. (2008) (115)
Balloon-Protected Carotid Artery Stenting: Relationship of Periprocedural Neurological Complications With the Size of Particulate Debris (2001) (115)
Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement: The Randomized BRAVO-3 Trial. (2015) (112)
Novel Drug-Delivery Stent: Intravascular Ultrasound Observations From the First Human Experience With the QP2-Eluting Polymer Stent System (2001) (102)
7-Hexanoyltaxol–Eluting Stent for Prevention of Neointimal Growth: An Intravascular Ultrasound Analysis From the Study to COmpare REstenosis rate between QueST and QuaDS-QP2 (SCORE) (2002) (102)
Six-month results of a randomized study to evaluate safety and efficacy of a Biolimus A9 eluting stent with a biodegradable polymer coating. (2005) (101)
[Percutaneous aortic valve replacement]. (2006) (101)
Impact of paravalvular leakage on outcome in patients after transcatheter aortic valve implantation. (2012) (100)
Heparin-Coated Stent Placement for the Treatment of Stenoses in Small Coronary Arteries of Symptomatic Patients (2003) (100)
BioMatrix® Biolimus A9®-eluting coronary stent: a next-generation drug-eluting stent for coronary artery disease (2006) (98)
Effectiveness and Safety of Sirolimus-Eluting Stents in the Treatment of Restenosis After Coronary Stent Placement (2005) (97)
Comparison of one- and 12-month outcomes of transcatheter aortic valve replacement in patients with severely stenotic bicuspid versus tricuspid aortic valves (results from a multicenter registry). (2014) (96)
Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial). (2005) (94)
Drug-eluting stents in the treatment of intermediate lesions: pooled analysis from four randomized trials. (2006) (89)
Development of a risk score for outcome after transcatheter aortic valve implantation (2014) (87)
Cognitive Trajectory After Transcatheter Aortic Valve Implantation (2013) (85)
Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial. (2004) (85)
Percutaneous implantation of the first repositionable aortic valve prosthesis in a patient with severe aortic stenosis (2008) (85)
Outcomes and predictors of mortality after transcatheter aortic valve implantation: Results of the Brazilian registry (2015) (84)
Six-month clinical and angiographic results of a dedicated drug-eluting stent for the treatment of coronary bifurcation narrowings. (2007) (83)
Transcatheter aortic valve implantation in patients with low-flow, low-gradient aortic stenosis. (2012) (83)
High-dose 7-hexanoyltaxol-eluting stent with polymer sleeves for coronary revascularization: one-year results from the SCORE randomized trial. (2004) (83)
A multicentre evaluation of the safety of intracoronary optical coherence tomography. (2009) (82)
Tryton I, First-In-Man (FIM) study: six month clinical and angiographic outcome, analysis with new quantitative coronary angiography dedicated for bifurcation lesions. (2008) (81)
Carotid artery revascularization in high surgical risk patients with the NexStent and the Filterwire EX/EZ (2008) (80)
Effect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials). (2006) (78)
Long-term impact of routinely detected early and late incomplete stent apposition: an integrated intravascular ultrasound analysis of the TAXUS IV, V, and VI and TAXUS ATLAS workhorse, long lesion, and direct stent studies. (2010) (77)
Relation of stent design and stent surface material to subsequent in-stent intimal hyperplasia in coronary arteries determined by intravascular ultrasound. (2002) (77)
Five‐year long‐term clinical follow‐up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: The SPIRIT FIRST trial (2010) (75)
The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation: results from the German Transcatheter Aortic Valve Interventions Registry. (2012) (71)
Angiographic results of the first human experience with the Biolimus A9 drug-eluting stent for de novo coronary lesions. (2006) (71)
Evaluation of a balloon occlusion and aspiration system for protection from distal embolization during stenting in saphenous vein grafts. (2002) (69)
Decrease of pulmonary hypertension impacts on prognosis after transcatheter aortic valve replacement. (2014) (68)
Symetis ACURATE TF™ aortic bioprosthesis. (2013) (66)
Network Analysis of Human In-Stent Restenosis (2006) (66)
Effects of gold coating of coronary stents on neointimal proliferation following stent implantation. (2002) (65)
An integrated TAXUS IV, V, and VI intravascular ultrasound analysis of the predictors of edge restenosis after bare metal or paclitaxel-eluting stents. (2009) (64)
Six-month results of a repositionable and retrievable pericardial valve for transcatheter aortic valve replacement: the Direct Flow Medical aortic valve. (2010) (64)
Long-term safety and efficacy of paclitaxel-eluting stents final 5-year analysis from the TAXUS Clinical Trial Program. (2011) (64)
The SPIRIT V diabetic study: a randomized clinical evaluation of the XIENCE V everolimus-eluting stent vs the TAXUS Liberté paclitaxel-eluting stent in diabetic patients with de novo coronary artery lesions. (2012) (64)
Chimney Stenting for Coronary Occlusion During TAVR: Insights From the Chimney Registry. (2020) (64)
Laser angioplasty of restenosed coronary stents: results of a multicenter surveillance trial. The Laser Angioplasty of Restenosed Stents (LARS) Investigators. (1999) (62)
TAXUS VI 2-year follow-up: randomized comparison of polymer-based paclitaxel-eluting with bare metal stents for treatment of long, complex lesions. (2007) (62)
TAXUS VI final 5-year results: a multicentre, randomised trial comparing polymer-based moderate-release paclitaxel-eluting stent with a bare metal stent for treatment of long, complex coronary artery lesions. (2009) (62)
The SPIRIT V study: a clinical evaluation of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions. (2011) (60)
Polymer-Free Biolimus A9-Coated Stents in the Treatment of De Novo Coronary Lesions: 4- and 12-Month Angiographic Follow-Up and Final 5-Year Clinical Outcomes of the Prospective, Multicenter BioFreedom FIM Clinical Trial. (2016) (60)
Intravascular Lithotripsy in Calcified Coronary Lesions: A Prospective, Observational, Multicenter Registry. (2019) (60)
Two-year-plus follow-up of a paclitaxel-eluting stent in de novo coronary narrowings (TAXUS I). (2005) (58)
Procedural and mid-term results in patients with aortic stenosis treated with implantation of 2 (in-series) CoreValve prostheses in 1 procedure. (2010) (57)
A novel paclitaxel-eluting stent with an ultrathin abluminal biodegradable polymer 9-month outcomes with the JACTAX HD stent. (2010) (55)
Volume–outcome relation for contemporary percutaneous coronary interventions (PCI) in daily clinical practice: is it limited to high-risk patients? Results from the Registry of Percutaneous Coronary Interventions of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK) (2007) (53)
Contemporary success and complication rates of percutaneous coronary intervention for chronic total coronary occlusions: results from the ALKK quality control registry of 2006. (2010) (53)
Predictors of restenosis after treatment of bifurcational lesions with paclitaxel eluting stents: A multicenter prospective registry of 150 consecutive patients (2007) (52)
Six-month clinical and angiographic results of the STENTYS® self-apposing stent in bifurcation lesions. (2011) (52)
1-Year Outcomes With the Evolut R Self-Expanding Transcatheter Aortic Valve: From the International FORWARD Study. (2018) (51)
Effect of the polymer-based, paclitaxel-eluting TAXUS Express stent on vascular tissue responses: a volumetric intravascular ultrasound integrated analysis from the TAXUS IV, V, and VI trials. (2007) (50)
Three-dimensional speckle-tracking analysis of left ventricular function after transcatheter aortic valve implantation. (2012) (50)
Treatment of in-stent restenosis using a paclitaxel-eluting stent: acute results and long-term follow-up of a matched-pair comparison with intracoronary beta-radiation therapy. (2004) (50)
Initial multicenter experience with a novel distal protection filter during carotid artery stent implantation (2003) (50)
Optical Coherence Tomography (OCT) (2003) (47)
Initial clinical experience with distal protection using the FilterWire in patients undergoing coronary artery and saphenous vein graft percutaneous intervention (2002) (46)
ABT-578-Eluting Stents (2004) (45)
First-in-man (FIM) study of the Stentys bifurcation stent--30 days results. (2009) (45)
Initial experience with paclitaxel-coated stents. (2002) (44)
Effects of octreotide treatment on restenosis after coronary angioplasty: results of the VERAS study. VErringerung der Restenoserate nach Angioplastie durch ein Somatostatin-analogon. (1997) (44)
The revised EuroSCORE II for the prediction of mortality in patients undergoing transcatheter aortic valve implantation (2013) (44)
Angiographic patterns of restenosis after paclitaxel-eluting stent implantation. (2005) (44)
Images in cardiovascular medicine. Intracoronary imaging with optical coherence tomography: a new high-resolution technology providing striking visualization in the coronary artery. (2002) (44)
Acute and long‐term outcomes of the novel side access (SLK‐View™) stent for bifurcation coronary lesions: A multicenter nonrandomized feasibility study (2006) (44)
Risk scores and biomarkers for the prediction of 1-year outcome after transcatheter aortic valve replacement. (2015) (43)
Transcatheter aortic valve implantation versus redo surgery for failing surgical aortic bioprostheses: a multicentre propensity score analysis. (2017) (43)
Intravascular ultrasound assessment of the novel AngioSculpt scoring balloon catheter for the treatment of complex coronary lesions. (2008) (42)
Transfemoral TAVI using the self-expanding ACURATE neo prosthesis: one-year outcomes of the multicentre "CE-approval cohort". (2017) (42)
Direct Transcatheter Heart Valve Implantation Versus Implantation With Balloon Predilatation: Insights From the Brazilian Transcatheter Aortic Valve Replacement Registry (2016) (41)
Rapamycin Analogs for Stent-Based Local Drug Delivery (2004) (40)
The prognostic value of acute and chronic troponin elevation after transcatheter aortic valve implantation. (2016) (40)
High-frequency mechanical vibration to recanalize chronic total occlusions after failure to cross with conventional guidewires. (2006) (39)
Tryton I, First-In-Man (FIM) Study: acute and 30 day outcome.A preliminary report. (2007) (38)
Drug eluting stents: initial experiences (2002) (37)
Comparison of a Complete Percutaneous versus Surgical Approach to Aortic Valve Replacement and Revascularization in Patients at Intermediate Surgical Risk: Results from the Randomized SURTAVI Trial. (2019) (37)
Testing prospectively the effectiveness and safety of paclitaxel-eluting stents in over 1000 very high-risk patients: design, baseline characteristics, procedural data and in-hospital outcomes of the multicenter Taxus in Real-life Usage Evaluation (TRUE) Study. (2007) (37)
Analysis of left main coronary artery bifurcation lesions treated with biolimus‐eluting DEVAX AXXESS plus nitinol self‐expanding stent: Intravascular ultrasound results of the AXXENT trial (2009) (36)
Prospective Multicenter Evaluation of the Direct Flow Medical Transcatheter Aortic Valve System: 12-Month Outcomes of the Evaluation of the Direct Flow Medical Percutaneous Aortic Valve 18F System for the Treatment of Patients With Severe Aortic Stenosis (DISCOVER) Study. (2016) (36)
Treatment of a degenerative stenosed CoreValve® aortic bioprosthesis by transcatheter valve‐in‐valve insertion (2012) (34)
Clinical and angiographic follow-up of small vessel lesions treated with paclitaxel-eluting stents (from the TRUE Registry). (2008) (34)
First human use of the TAXUS Petal paclitaxel-eluting bifurcation stent. (2010) (33)
Serial intravascular ultrasound analysis of bifurcation lesions treated using the novel self-expanding sideguard side branch stent. (2009) (33)
Two-year results of a durable polymer everolimus-eluting stent in de novo coronary artery stenosis (The SPIRIT FIRST Trial). (2007) (33)
Coronary Protection to Prevent Coronary Obstruction During TAVR (2020) (33)
Direct Stenting with TAXUS Stents Seems to be as Safe and Effective as with Predilatation (2004) (33)
Percutaneous Recanalization of Chronically Occluded Coronary Arteries A New Drugs and Technologies (2005) (33)
Sodium intake modulates left ventricular hypertrophy in essential hypertension (1988) (33)
Prognostic value of cerebral injury following transfemoral aortic valve implantation. (2013) (32)
In-hospital outcomes after elective and non-elective percutaneous coronary interventions in hospitals with and without on-site cardiac surgery backup (2009) (31)
A randomized, controlled, multicenter trial to evaluate the safety and efficacy of zotarolimus- versus paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries The ZoMaxx I trial. (2008) (31)
Pre-Procedural Hemodynamic Status Improves the Discriminatory Value of the Aortic Regurgitation Index in Patients Undergoing Transcatheter Aortic Valve Replacement. (2016) (31)
Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: A post hoc analysis from the BRAVO‐3 randomized trial (2019) (30)
Everolimus for stent-based intracoronary applications. (2004) (30)
Next-generation transcatheter heart valves: current trials in Europe and the USA. (2012) (30)
Medtronic CoreValve Evolut R with EnVeo R. (2013) (28)
Safety of direct stenting with the Endeavor stent: results of the Endeavor II continued access registry. (2007) (28)
Routine Endovascular Treatment With a Stent Graft for Access-Site and Access-Related Vascular Injury in Transfemoral Transcatheter Aortic Valve Implantation (2016) (28)
Impact of left ventricular conduction defect with or without need for permanent right ventricular pacing on functional and clinical recovery after TAVR (2015) (27)
Analysis of bifurcation lesions treated with novel drug‐eluting dedicated bifurcation stent system: Intravascular ultrasound results of the AXXESS PLUS trial (2007) (27)
MOONLIGHT: a controlled registry of an iridium oxide-coated stent with angiographic follow-up. (2004) (27)
Determinants of mortality after cardiac surgery: results of the registry of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK) on 10 525 patients. (2000) (27)
Coronary stenting with MGuard: first-in-man trial. (2008) (27)
Periprocedural Myocardial Injury Depends on Transcatheter Heart Valve Type But Does Not Predict Mortality in Patients After Transcatheter Aortic Valve Replacement. (2017) (27)
First clinical experience with Celt ACD(®) : a femoral arterial puncture closure device. (2013) (27)
Outcome Self-Expanding CoreValve Prosthesis: Device Success and 30-Day Clinical High-Risk Patients Using the Second- and Current Third-Generation Percutaneous Aortic Valve Replacement for Severe Aortic Stenosis in (2007) (26)
Impact of coronary artery disease in patients undergoing transfemoral transcatheter aortic valve implantation. (2017) (26)
First-in-man transapical mitral valve replacement using the Direct Flow Medical® aortic valve prosthesis. (2015) (26)
Current periprocedural anticoagulation in transcatheter aortic valve replacement: could bivalirudin be an option? Rationale and design of the BRAVO 2/3 studies (2013) (26)
An overview of the TAXUS Express, paclitaxel-eluting stent clinical trial program. (2006) (25)
Intracoronary Imaging With Optical Coherence Tomography (2002) (25)
Medtronic CoreValve Evolut valve. (2012) (24)
Doppler-based renal resistance index for the detection of acute kidney injury and the non-invasive evaluation of paravalvular aortic regurgitation after transcatheter aortic valve implantation. (2014) (24)
The Year in Cardiology 2013: valvular heart disease (focus on catheter-based interventions). (2014) (23)
Polymer‐based paclitaxel‐eluting stent for treatment of chronic total occlusions of native coronaries: Results of a Taxus CTO registry (2005) (22)
Transcatheter aortic valve implantation: the evidence (2012) (22)
Clinical experiences using everolimus-eluting stents in patients with coronary artery disease. (2004) (22)
Influence of plaque calcium on neointimal hyperplasia following bare metal and drug‐eluting stent implantation (2006) (22)
Comparison of ticlopidine vs. clopidogrel in addition to aspirin after paclitaxel-eluting stent implantation: insights from the TRUE (Taxusin Real-life Usage Evaluation) Study. (2006) (21)
Meta-analysis of angiographic versus intravascular ultrasound parameters of drug-eluting stent efficacy (from TAXUS IV, V, and VI). (2007) (21)
Left main PCI after trans-subclavian CoreValve implantation. Successful outcome of a combined procedure for management of a rare complication (2009) (21)
One-year outcomes after direct transcatheter aortic valve implantation with a self-expanding bioprosthesis. A two-center international experience. (2016) (21)
Non-invasive diagnosis of a false left ventricular aneurysm by echocardiography and pulsed Doppler echocardiography. (1980) (21)
Direct Flow Medical valve. (2012) (21)
Hydrodynamic Performance of the Medtronic CoreValve and the Edwards SAPIEN XT Transcatheter Heart Valve in Surgical Bioprostheses: An In Vitro Valve-in-Valve Model. (2016) (20)
Combination of angiographic and clinical characteristics for the prediction of clinical outcomes in elderly patients undergoing multivessel PCI (2013) (20)
Soluble ST2 for Risk Stratification and the Prediction of Mortality in Patients Undergoing Transcatheter Aortic Valve Implantation. (2017) (20)
Effect of prolonged thienopyridine use after drug-eluting stent implantation (from the TAXUS landmark trials data). (2008) (20)
The "Big Five" Complications After Transcatheter Aortic Valve Replacement: Do We Still Have to Be Afraid of Them? (2019) (19)
Integrated analysis of medically treated diabetic patients in the TAXUS(R) program: benefits across stent platforms, paclitaxel release formulations, and diabetic treatments. (2006) (19)
Carotid artery revascularisation in high-surgical-risk patients with the NexStent and the FilterWire EX/EZ: 3-year results from the CABERNET trial. (2010) (19)
Intravenous quinidine: pharmacokinetic properties and effects on left ventricular performance in humans☆ (1980) (19)
Relation of hemodynamic reaction during stress to left ventricular hypertrophy in essential hypertension. (1990) (19)
Safety and Efficacy of Protamine Administration for Prevention of Bleeding Complications in Patients Undergoing TAVR. (2020) (19)
Transcatheter Annuloplasty for Mitral Regurgitation with an Adjustable Semi-Rigid Complete Ring: Initial Experience with the Millipede IRIS Device (2018) (19)
SCOREO trial interim safety results: despite efficacy, late stent thrombosis with the QuaDDS-QP2 stent (2002) (18)
One year results of a new in situ length-adjustable stent platform with a biodegradable biolimus A9 eluting polymer: results of the CUSTOM-II trial. (2008) (18)
Randomized, double‐blind, multicenter study of the polymer‐based 17‐β estradiol‐eluting stent for treatment of native coronary artery lesions: Six‐month results of the ETHOS I trial (2007) (18)
Impact of In-Stent Minimal Lumen Area at 9 Months Poststent Implantation on 3-Year Target Lesion Revascularization–Free Survival: A Serial Intravascular Ultrasound Analysis From the TAXUS IV, V, and VI Trials (2008) (18)
Age-stratified baseline and outcome characteristics of patients undergoing transcatheter aortic valve implantation: results from the German multicenter registry. (2012) (18)
Subacute Subclinical Brain Infarctions after Transcatheter Aortic Valve Implantation Negatively Impact Cognitive Function in Long-Term Follow-Up (2017) (18)
Meta-analysis of the effects of paclitaxel-eluting stents versus bare metal stents on volumetric intravascular ultrasound in patients with versus without diabetes mellitus. (2008) (17)
[Demonstration of left-ventricular contraction anomalies with the two-dimensional sector-scanner (author's transl)]. (1979) (17)
An exceptional case of frame underexpansion with a self-expandable transcatheter heart valve despite predilation. (2012) (17)
Initial clinical experience with the Coherex FlatStent™ and FlatStent™ EF PFO closure system for in‐tunnel PFO closure: Results of the Coherex‐EU study (2014) (17)
Paclitaxel-Eluting Stents (2004) (17)
Validation of a thermographic guidewire for endoluminal mapping of atherosclerotic disease: An in vitro study (2004) (16)
[Modification of myocardial function parameters by L- and D-penbutolol--an echocardiography, placebo-controlled double-blind study]. (1985) (16)
Balloon post-dilation and valve-in-valve implantation for the reduction of paravalvular leakage with use of the self-expanding CoreValve prosthesis. (2016) (16)
A clinical protocol for analysis of the structural integrity of the Medtronic CoreValve System frame and its application in patients with 1-year minimum follow-up. (2010) (16)
A method for standardized computed tomography angiography-based measurement of aortic valvar structures. (2010) (16)
Coronary stenting with MGuard: extended follow-up of first human trial. (2011) (15)
Prevalence and Impact of Sleep Disordered Breathing in Patients with Severe Aortic Stenosis (2015) (15)
First-In-Man application of a miniature self-contained intracoronary magnetic resonance probe. A multi-centre safety and feasibility trial. (2006) (15)
Coronary Protection to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement: A Multicenter International Registry. (2020) (15)
Drug-eluting stents: clinical experiences and perspectives. (2002) (15)
Automatic Contour Finding and Digital Subtraction Technique in 2-Dimensional Echocardiography (1987) (15)
Pharmacokinetic and Pharmacodynamic Properties of Ramipril in Patients with Congestive Heart Failure (NYHA III‐IV) (1989) (15)
Opportunistic Computed Tomography Imaging for the Assessment of Fatty Muscle Fraction Predicts Outcome in Patients Undergoing Transcatheter Aortic Valve Replacement. (2020) (14)
[Percutaneous suture of femoral artery access sites after diagnostic heart catheterization and or coronary intervention. Safety and effectiveness of a new arterial suture technic]. (1998) (14)
Permanent Pacemaker Implantation after TAVR - Predictors and Impact on Outcomes. (2015) (14)
Early Insight into Mitralign Direct Annuloplasty for Treatment of Functional Mitral Regurgitation (2011) (14)
Computerized two-lead resting ECG analysis for the detection of coronary artery stenosis (2007) (14)
Potential of a New High-Resolution Intracoronary Imaging Technique (2003) (14)
Mechanisms of lumen narrowing of saphenous vein bypass grafts 12 months after implantation: An intravascular ultrasound study (2006) (14)
Comparison of vascular response to zotarolimus-eluting stent vs paclitaxel-eluting stent implantation: pooled IVUS results from the ZoMaxx I and II trials. (2010) (14)
Computerized two-lead resting ECG analysis for the detection of coronary artery stenosis after coronary revascularization (2008) (14)
Outcome in TAVI patients with symptomatic aortic stenosis not fulfilling PARTNER study inclusion criteria (2015) (13)
Percutaneous aortic valve replacement for the treatment of aortic stenosis: early experience in Brazil. (2009) (13)
Final report of the European multi-center registry using the Deutt™ vascular sealing device (1999) (13)
Complete percutaneous approach versus surgical access in transfemoral transcatheter aortic valve implantation: results from a multicentre registry. (2018) (13)
Caval Valve Implantation for Treatment of Severe Tricuspid Regurgitation. (2018) (13)
Early versus newer generation transcatheter heart valves for transcatheter aortic valve implantation: Echocardiographic and hemodynamic evaluation of an all-comers study cohort using the dimensionless aortic regurgitation index (AR-index) (2019) (13)
Predictors of Permanent Pacemaker Insertion Following Transcatheter Aortic Valve Replacement With the CoreValve Revalving System Based on Computed Tomography Analysis: An Asian Multicenter Registry Study. (2014) (13)
Adjunctive use of the Rinspiration system for fluidic thrombectomy during primary angioplasty: The Rinspiration international registry (2008) (13)
Treatment of uncrossable chronic total coronary occlusions with the frontrunner: multicenter experience (2002) (12)
Chronic arterial responses to overlapping paclitaxel-eluting stents: insights from serial intravascular ultrasound analyses in the TAXUS-V and -VI trials. (2008) (12)
[Improving color Doppler echocardiography of the right heart chambers following intravenous injection of SHU 454]. (1988) (12)
[Percutaneous suture closure of the femoral artery access after diagnostic heart catheter examination or coronary intervention]. (2008) (12)
CoreValve degeneration with severe transvalvular aortic regurgitation treated with valve-in-valve implantation. (2014) (12)
Thirty-day Clinical Outcomes of the Evolut PRO Self-Expanding Transcatheter Aortic Valve: The International FORWARD PRO Study. (2020) (12)
Safety and efficacy of multiple, overlapping polymer-based paclitaxel-eluting stents. (2007) (12)
A randomized, controlled, multicenter trial to evaluate the safety and efficacy of Zotarolimus‐ vs. Paclitaxel‐eluting stents in de novo occlusive lesions in coronary arteries: Five‐year results from the ZOMAXX I trial (2013) (11)
Catheter-Based Edge-to-Edge Mitral Valve Repair After Partial Rupture of Surgical Annuloplasty Ring. (2015) (11)
SCORE six-month angiographic results: improved restenosis in patients receiving the QUADDS-QP2 drug-eluting stent compared with the control, bare stents (2002) (11)
Novel drug eluting stent system for customised treatment of coronary lesions: CUSTOM I feasibility trial 24 month results. (2008) (11)
Two‐year outcomes after deployment of XIENCE V everolimus‐eluting stents in patients undergoing percutaneous coronary intervention of bifurcation lesions: A report from the SPIRIT V single arm study (2013) (11)
Evaluation of a tarcolimus-eluting coronary stent with nanoporous ceramic coating in treatment of native coronary artery lesions: Phase I and II of the PRESENT study (2003) (11)
Transcatheter valve implantation improves central sleep apnoea in severe aortic stenosis. (2013) (11)
Mechanisms of lumen narrowing of saphenous vein bypass grafts 12 months after implantation: an intravascular ultrasound study. (2002) (10)
Percutaneous transluminal coronary angioplasty of left main stenosis – results of the German PTCA registry (2000) (10)
THE BOSTON SCIENTIFIC ANTIPROLIFERATIVE , PACLITAXEL ELUTING STENTS ( TAXUS ) (2001) (10)
Incidental finding of a papillary fibroelastoma on the aortic valve in 16 slice multi-detector row computed tomography (2004) (10)
The new coronary stent Graft JoStent®: first clinical experience (1998) (10)
[Automatic contour detection in the 2-dimensional echocardiogram--studies in a general patient population]. (1985) (10)
First-in-man assessment of the InSeal VCD, a novel closure device for large puncture accesses. (2015) (10)
Novel approaches for prevention of stroke related to transcatheter aortic valve implantation (2013) (10)
Three-dimensional imaging of the aortic valve geometry for prosthesis sizing prior to transcatheter aortic valve replacement. (2014) (9)
A permanent solution for a temporary problem: transcatheter valve-in-valve implantation for failed transcatheter aortic valve replacement. (2012) (9)
Transcatheter aortic valve implantation through a diseased left common carotid artery: Combined approach with endarterectomy and left carotid‐subclavian bypass (2013) (9)
The Quanam QuaDDS-QP2 Stent (2001) (9)
[Automatic and semiautomatic contour finding of the left ventricle in the 2 dimensional echocardiogram. In vitro studies in formalin-fixed swine hearts]. (1985) (9)
Coronary stents: In vitro aspects of an angiographic and ultrasound quantification with in vivo correlation. (1998) (9)
[Assessment of the severity of mitral valve insufficiency using color Doppler echocardiography]. (1989) (9)
Impact of Drug-Eluting Stents on Distal Vessels (2012) (9)
Risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 German patients (2020) (9)
Advances in percutaneous treatment for adult valvular heart disease (2009) (9)
First experience with the Impella Recover(R) LP 2.5 micro axial pump in patients with cardiogenic shock or undergoing high-risk revascularisation. (2006) (9)
TCT-46 Comparison of Polymer-Free BioFreedom™ Stents with Durable Polymer Taxus Liberté™ Stents: 3-Year Results from the BioFreedom First-In-Man Trial (2012) (9)
Combination of angiographic and clinical characteristics for the prediction of clinical outcomes in patients undergoing unprotected left main coronary artery stenting (2012) (8)
Safety and performance of a paclitaxel-eluting stent for the treatment of in-stent restenosis: preliminary results of the taxus III trial (2002) (8)
CD-144 positive endothelial microparticles are increased in patients with systemic inflammatory response syndrome after TAVI. (2016) (8)
TCT-107 Transcatheter Aortic Valve Replacement with a Self-Expanding Prosthesis or Surgical Aortic Valve Replacement in Intermediate-Risk Patients: Complete 1-Year Outcomes from the SURTAVI Trial (2017) (8)
First human experience using a new everolimus stent coating: Procedural and six-month follow-up results of the FUTURE trial (2003) (8)
Current Concepts in the Treatment of Cardiac Arrhythmias (1986) (8)
Challenges in transcatheter valve treatment: aortic regurgitation after transcatheter aortic valve implantation. (2013) (8)
[Determinants for myocardial hypertrophy in mild essential hypertension. The effect of sodium chloride on left-ventricular hypertrophy]. (1990) (8)
Early experience with a novel plaque excision system for the treatment of complex coronary lesions (2004) (8)
Paclitaxel-eluting stents: current clinical experience. (2004) (8)
Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 5-Year Outcomes of the SURTAVI Randomized Clinical Trial. (2022) (8)
The development of door-to-angiography time in the last 14 years for patients with acute ST-elevation myocardial infarction treated with primary coronary intervention: Determinants and outcome. Results from the MITRAplus and OPTAMI registry (2011) (8)
STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION: LONG-TERM RESULTS AFTER 6 YEARS OF THE WATCHMAN LEFT ATRIAL APPENDAGE OCCLUSION PILOT STUDY (2011) (8)
Long-term follow-up (four years) of unprotected left main coronary artery disease treated with paclitaxel-eluting stents (from the TRUE Registry) (2010) (8)
Four-year experience with the CoreValve transcatheter heart valve. (2016) (7)
FX MiniRAIL catheter usage for treatment of de novo complex coronary lesions: results from the "OFFAR". (2006) (7)
Appraising the effectiveness and safety of paclitaxel-eluting stents in over 1,000 very high-risk patients: overall results of the Taxus in Real-life Usage Evaluation (TRUE) registry. (2007) (7)
Innovations and novel technologies in TAVI. Second generation transcatheter heart valves. (2013) (7)
[Computer assisted determination of left-ventricular contraction abnormalities using two-dimensional echocardiography. I. Analysis various study methods and determination of normal values]. (1984) (7)
Impact of Tricuspid Regurgitation in Patients Undergoing Transcatheter Aortic Valve Replacement. (2020) (7)
Percutaneous suturing of femoral artery access sites after diagnostic cardiac catheterization or coronary intervention (1997) (7)
Pharmacokinetics and pharmacodynamics of intravenous digoxin and digitoxin (1981) (7)
[Brugada syndrome or ARVD (arrhythmogenic right ventricular dysplasia) or both? Significance and value of right precordial ECG changes]. (2002) (7)
Impact of side branch stenting on five-year long-term clinical outcome with the bifurcation-dedicated Axxess Biolimus A9-eluting stent system. (2015) (7)
The Lunar Stent (2002) (7)
Fractional flow reserve in patients with coronary artery disease undergoing TAVI: a prospective analysis (2019) (7)
Combination of high-sensitivity C-reactive protein with logistic EuroSCORE improves risk stratification in patients undergoing TAVI. (2018) (6)
Kinetics and cardiac effects of propranolol in humans (1982) (6)
Evaluation of a new polymer-coated paclitaxel-eluting stent for treatment of de novo lesions: six-month clinical and angiographic follow-up results of the APPLAUSE trial. (2006) (6)
Impact of Hemodynamic Support on Outcome in Patients Undergoing High-Risk Percutaneous Coronary Intervention. (2019) (6)
The ProLimus trial: a prospective, non-randomised, multicentre trial to evaluate the safety and clinical performance of the pimecrolimus eluting stent system (ProGenic). (2009) (6)
[Fast computer tomography for investigation of the heart--"computer cardiotomography". Methods and early results (author's transl)]. (1978) (6)
Experience with CoreValve aortic valve replacement in patients for surgical aortic valve replacement (2008) (6)
Transcatheter Aortic Valve Implantation: Upcoming New Devices. (2012) (6)
Treatment of In-Stent restenosis using a stent with non-polymer-based paclitaxel elution. (2004) (6)
Direct stent implantation using the EXPRESS Coronary Stent System: results of a multi-center feasibility study. (2003) (6)
Comparative endoluminal visualization of TAXUS crush-stenting at 9 months follow-up by intravascular ultrasound and optical coherence tomography (2005) (6)
Predictive factors and long-term prognosis of transcatheter aortic valve implantation-associated endocarditis (2020) (6)
Saphenous vein graft stenting using a novel filter device for distal protection. (2003) (6)
Use of Taxus polymer‐coated paclitaxel‐eluting stents for treatment of in‐stent restenosis in real world patients: Results of clinical and angiographic follow‐up at six months in a single‐center registry (2006) (6)
[Determination of the severity of mitral stenosis by hemodynamic and echocardiographic parameters]. (1978) (5)
Evaluation of the XIENCE V everolimus eluting coronary stent system in the Asian population of the SPIRIT V single arm study. 2-year clinical follow-up data. (2011) (5)
843-2 Everolimus-eluting stents for the prevention of restenosis: Results of the FUTURE II trial (2004) (5)
[Improved reproducibility of contrast echocardiography by SH U 454. Experimental studies using digital subtraction echocardiography]. (1986) (5)
Predictive Value of the Platelet-to-Lymphocyte Ratio in Cancer Patients Undergoing Transcatheter Aortic Valve Replacement (2019) (5)
Use of a balloon-expandable transfemoral sheath in a TAVI cohort with complex access site - a propensity score matched analysis. (2015) (5)
TAVR outcome after reclassification of aortic valve stenosis by using a hybrid continuity equation that combines computed tomography and echocardiography data (2020) (5)
Prognostic value of cerebral injury following transfemoral aortic valve implantation. (2012) (5)
[Computer tomographic diagnosis of cardiac, pericardial and paracardial space occupying lesions]. (1981) (5)
[Percutaneous aortic valve replacement - pro]. (2009) (5)
Clinical and angiographic performance of a new‐generation modular stent design for treatment of de novo coronary lesions (2001) (5)
Intravenous quinidine: pharmacokinetic properties and effects on left ventricular performance in humans. (1981) (5)
Angiographic, intravascular ultrasound, and fractional flow reserve evaluation of direct stenting vs. conventional stenting using BeStent2 in a multicentre randomized trial. (2005) (5)
The CoreValve in the aortic position (2006) (5)
[State of treatment of coronary artery disease by drug releasing stents]. (2002) (5)
1495 Everolimus stent coating: promising procedural and 6-month angiographic and intravascular ultrasound follow-up results of the FUTURE I and II trial (2003) (5)
Transcatheter aortic valve implantation and closure of the left atrial appendage under cerebral protection. (2012) (5)
Serial intravascular ultrasound analysis of stent strut distribution and fracture: an integrated analysis of the taxus IV, V, and VI trials. (2014) (5)
Substitution of ethanol with specially designed microspheres in a TASH procedure. (2011) (5)
Intraoperative cell-cycle blockade therapy using E2F decoy for prevention of early atherosclerosis in coronary bypass vein grafts: a volumetric IVUS subanalysis from a prospective randomized double blind clinical trial (2002) (4)
High-Frequency Annular Array Transesophageal Probe for High-Resolution Imaging and Continuous Wave Doppler Measurements (1989) (4)
[Evaluation of aortic valve insufficiency using color Doppler echocardiography]. (1987) (4)
Long-term follow-up (four years) of unprotected left main coronary artery disease treated with paclitaxel-eluting stents (from the TRUE Registry). (2010) (4)
DE NOVO CORONARY LESIONS TREATED WITH THE NOVEL POLYMER-FREE BIOLIMUS-A9 COATED STENTS: 12-MONTH ANGIOGRAPHIC RESULTS FROM THE PROSPECTIVE RANDOMIZED MULTICENTER BIOFREEDOM CLINICAL TRIAL (2011) (4)
[Clinical experiences with the PercuSurge GuardWire--a new system for prevention of peripheral embolisms in catheter interventions on degenerated coronary artery venous bypasses]. (2000) (4)
Optical coherence tomography imaging of thrombus protrusion through stent struts after stenting in acute coronary syndrome (2005) (4)
Frequency of coronary artery bypass grafting following implantation of a paclitaxel-eluting or a bare-metal stent into a single coronary artery. (2009) (4)
Drug-Eluting Stents in the Treatment of Intermediate Lesions (2006) (4)
Effects of the QUADDS-QP2 drug-eluting stent extend beyond the targeted area into adjacent nonstented zones: results of the SCORE trial (2002) (4)
The Medtronic transcatheter mitral valve implantation system. (2015) (4)
[Quantitative, computer-aided determination of left ventricular contraction abnormalities in two-dimensional echocardiography. II. Application in patients with coronary heart disease]. (1984) (4)
1044-56 Paclitaxel-eluting stent in complicated lesions or patient subsets: A subanalysis from the TAXUS II study (2004) (4)
[Fungal endocarditis of the tricuspid valve in Crohn disease]. (1987) (4)
Frailty, malnutrition, and the endocrine system impact outcome in patients undergoing aortic valve replacement (2021) (3)
Use of Pre- and Intensified Postprocedural Physiotherapy in Patients with Symptomatic Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement Study (the 4P-TAVR Study) (2021) (3)
Subclavian Access for Transcatheter CoreValve ® Aortic Prosthesis Implantation: Data from the Brazilian Registry (2012) (3)
[Temporal trends in the use of drug-eluting stents in German clinical practice]. (2008) (3)
[A rare pacemaker complication of a perforation by a ventricular screw electrode causing hemothorax]. (1986) (3)
Impact of Coronary Artery Disease on Outcomes in Patients Undergoing Percutaneous Edge-to-Edge Repair. (2020) (3)
Efficacy and feasibility of helixcision for debulking neointimal hyperplasia for in‐stent restenosis (2002) (3)
Prospective non-randomized multi-centre evaluation of the non-polymer based ACHIEVE Paclitaxel Eluting Coronary Stent System in treatment of lesions with high risk of revascularization due to restenosis: the DELIVER II study. (2006) (3)
Initial and follow-up results of the European Seaquence coronary stent registry. (2004) (3)
[Echocontrast ventriculography. Determination of left ventricular functional parameters with special reference to digital subtraction echocardiography]. (1986) (3)
Predictors of 30-day Mortality after Transcatheter Aortic Valve Implantation - Results from the Expanded Evaluation Registry with the 3rd Generation CoreValve ReValving System (2009) (3)
Impact of coronary artery disease on in-hospital mortality in patients with aortic valve disease (2013) (3)
Incidence, time course and predictors of early vs. late target lesion revascularisation after everolimus-eluting stent implantation: a SPIRIT V substudy. (2013) (3)
Images in cardiology. Optical coherence tomography imaging of thrombus protrusion through stent struts after stenting in acute coronary syndrome. (2006) (3)
Trans-catheter percutaneous aortic valve implantation for severe inoperable aortic valve stenosis: where do we stand? (2010) (3)
Intravenous quinidine in congestive cardiomyopathy (1981) (3)
Local intra-renal fenoldopam infusion causes greater increases in renal artery flow velocity than systemic intravenous fenoldopam infusion: a pilot study. (2005) (3)
1059-6 The multicenter evaluation of the everolimus-eluting stent for inhibition of neointimal hyperplasia: Results of the pooled FUTURE I and II trials (2004) (3)
Antegrade transcatheter mitral valve-in-valve implantation with combined atrial septal defect closure (2016) (3)
Impact of mild or moderate renal insufficiency on the intravascular ultrasonic analysis of chronic vascular response to paclitaxel-eluting and bare-metal stents (from the TAXUS IV, V, and VI trials). (2008) (3)
Computertomographische Diagnostik des Perikardergusses (1979) (2)
TCTAP A-161 Comparison of Next Generation Transcatheter Heart Valves: Angiographic, Echocardiographic and Hemodynamic Evaluation of an Extended All-comers Study Cohort Using the Dimensionless Aortic Regurgitation Index (2017) (2)
Impact of preoperative mitral regurgitation on outcome after Transcatheter Aortic Valve Implantation: results of the German TAVI registry (2013) (2)
Mitralign Percutaneous Annuloplasty System for the Treatment of Functional Mitral Regurgitation (2010) (2)
[Position paper on the use of drug eluting stents in coronary heart disease]. (2004) (2)
[Determination of left ventricular global ejection fraction using ECG-gated cardiac computed tomography]. (1985) (2)
How should I treat a patient with a stenosed bicuspid aortic valve and an unexpected finding during TAVI? (2014) (2)
About the use of the ACHIEVE paclitaxel eluting stent in treatment of restenotic lesions: A subanalysis of the 30-day safety data of DELIVER II (2003) (2)
OCT findings in drug-eluting stents (2007) (2)
Serial intravascular ultrasound observations from the Tryton first-in-man study. (2014) (2)
The Justified Revival of a Well-known Technique (2009) (2)
Successful post-dilation of a Lotus transcatheter aortic valve in a case of prosthesis frame underexpansion due to leaflet calcification. (2015) (2)
Transcatheter heart valve failure: the sword of Damocles over our heads? (2015) (2)
[Accuracy of cardiac CT and echocardiography in the diagnosis of space-occupying processes in the heart]. (1986) (2)
RISK SCORES AND BIOMARKERS FOR THE PREDICTION OF 1-YEAR OUTCOME AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT (2015) (2)
The Boston Scientific Antiproliferative, Paclitaxel Eluting Stents (TAXUS) (2001) (2)
Optimal protamine‐to‐heparin dosing ratio for the prevention of bleeding complications in patients undergoing TAVR—A multicenter experience (2022) (2)
Three-dimensional IVUS assessment of edge effects following drug-eluting stent implantation (2002) (2)
Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve Implantation (2022) (2)
The 9-month results of the TROPICAL study: A multicenter nonrandomized study of the cypher sirolimus-eluting stent in the treatment of patients with an in-stent restenotic native coronary artery lesion (2004) (2)
Final 3‐year clinical outcomes following transcatheter aortic valve implantation with a supra‐annular self‐expanding repositionable valve in a real‐world setting: Results from the multicenter FORWARD study (2021) (2)
Percutaneous trans-axilla transcatheter aortic valve replacement (2022) (2)
O renascimento justificado de uma técnica bem conhecida (2009) (2)
Mini-Focus: Aortic Valve DiseaseEditorial CommentUnbreak My Heart (Valve): Can Ultrasound Be Used for the Treatment of a Degenerated Surgical Bioprosthesis?∗ (2017) (1)
[Cyanotic patient with right ventricular dilatation and ventricular arrhythmias]. (1987) (1)
Elective Coronary Stenting as an Adjunct to Balloon Angioplasty in Stable Coronary Artery Disease: No Association with Incidence of Acute Complications. Results of the PTCA Registry of the German Community Hospitals (2000) (1)
Der perkutane Aortenklappenersatz - ein Update (2008) (1)
Incidence, predictors, and prognostic value of periprocedural myocardial injury after TAVI (2013) (1)
Vascular Access in Patients With Peripheral Arterial Disease Undergoing TAVR: The Hostile Registry. (2023) (1)
DIRECT TRANSCATHETER AORTIC VALVE REPLACEMENT VERSUS IMPLANTATION WITH BALLOON PREDILATATION: INSIGHTS FROM THE BRAZILIAN TAVR REGISTRY (2016) (1)
Indoramin in Severe Congestive Heart Failure (1986) (1)
New Alternative in Embolic Protection The Mesh Covered MGuard Stent (2007) (1)
COMPARISON OF PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE IMPLANTATION WITH AND WITHOUT BALLOON AORTIC PREDILATATION. IN-HOSPITAL AND LONG-TERM MORTALITY (2015) (1)
Valvular Heart Disease Aortic Regurgitation Index Defines Severity of Peri-Prosthetic Regurgitation and Predicts Outcome in Patients After Transcatheter Aortic Valve Implantation (2012) (1)
P918Tricuspid regurgitation in patients undergoing transcatheter aortic valve implantation (2019) (1)
TRANS-AORTIC IMPLANTATION OF THE MEDTRONIC COREVALVE PROSTHESIS. SUCCESSFUL IMPLANTATION THROUGH AN ALTERNATIVE ACCESS ROUTE (2010) (1)
[Intestinal absorption and metabolism of lanatoside C]. (1978) (1)
[Optical coherence tomography imaging in coronary drug-eluting stenting]. (2005) (1)
Very Long Term Clinical Outcomes of Patients with Coronary Bifurcation Lesions Treated with the Biolimus A9 Coated Dedicated Axxess Stent: Results from the Prospective, Multicenter AXXESS Plus Trial (Final Report of the Study) (2011) (1)
Helical atheractomy for in-stent restenosis: acute and long-term results from the helixcision™ endoluminal in-stent excision (HELIX 1) international feasibility trial (2002) (1)
COMPARISON OF TRANSFEMORAL AND TRANSAPICAL AORTIC VALVE REPLACEMENT: RESULTS OF THE GERMAN REGISTRY ON TRANSCATHETER AORTIC VALVE IMPLANTATIONS (2010) (1)
[Clinical and haemodynamic results with intra-aortic counterpulsation (author's transl)]. (1975) (1)
Abstract 13496: Aortic Regurgitation Index Defines Severity of Periprosthetic Regurgitation and Predicts Outcome in Patients after Tavi: A Two-Centre Experience (2012) (1)
Development of a risk score predicting 1-year mortality after transcatheter aortic valve implantation (2014) (1)
A Bicuspid Aortic Valve Imaging Classi ﬁ cation for the TAVR Era (2016) (1)
Transcatheter bioprosthesis implantation for the treatment of aortic stenosis: three-year experience. (2012) (1)
TCT-14 Very Long-term Results of BioFreedom First-In-Man, a Randomized Trial comparing Polymer-Free BioFreedom(tm) stents with Durable Polymer Taxus Liberté(tm) Stents (2013) (1)
Optimal endpoint for drug-eluting stent: predictive value of minimum stent area for long-term stent patency (2002) (1)
Two sides to every story: the trade-off between paravalvular leakage and the occurrence of conduction disturbances in transcatheter heart valves. (2017) (1)
The lunar stent characteristics and clinical results. (2002) (1)
First-in-man experience of percutaneous aortic valve replacement using self-expanding corevalve prosthesis. (2011) (1)
INCIDENCE OF ACUTE KIDNEY INJURY WITH BIVALIRUDIN OR UNFRACTIONATED HEPARIN FOLLOWING TRANSCATHETER AORTIC VALVE REPLACEMENT: RESULTS FROM THE BRAVO-3 RANDOMIZED TRIAL (2017) (1)
[Background and indications for distal protection devices in percutaneous coronary interventions]. (2006) (1)
The Boston Scientific paclitaxel eluting stent: TAXUS I and II (2005) (1)
Prospective evaluation of the aortic regurgitation index in TAVI patients (2013) (1)
[Intraoperative measurement of velocity and volume of coronary circulation using the Duplex system]. (1988) (1)
Transcatheter Triple-Valve Intervention. (2021) (1)
THE QUANAM QUADDS-QP 2 STENT (2001) (1)
Transcatheter aortic valve implantation in nonagenarians - old…but not obsolete! (2020) (0)
Abstract 19332: Results of Transfemoral Transcatheter Aortic Valve Implantation in Partner-Like Patients - A Comparison with Real-World Patients - The Bonn-Essen Experience (2012) (0)
Abstract 1741: Predicting Coronary Stenosis by Computer-Enhanced, Resting Electrocardiogram: Effect of Gender, Age, and Revascularization on Sensitivity and Specificity (2007) (0)
P973Intravascular lithotripsy for lesion preparation in calcified coronary lesions: a prospective, observational, two-center registry (2019) (0)
SIX YEARS OPTICAL COHERENCE TOMOGRAPHY, INTRAVASCULAR ULTRASOUND, AND QUANTITATIVE CORONARY ANGIOGRAPHY FOLLOW-UP OF PATIENTS WITH CORONARY LESIONS TREATED WITH THE BIOLIMUS A9-ELUTING STENTS WITH A BIOABSORBABLE POLYMER (2010) (0)
Transcatheter aortic valve replacement: many roads lead to Rome...but the implantation technique makes the difference! (2013) (0)
TCTAP A-118 12 Months Results from a CE Mark Trial of a 2nd Generation, Self-Expanding, Transfemoral Aortic Bioprosthesis for the Treatment of Patients with Severe Aortic Stenosis (2015) (0)
The Quanam drug-eluting stent and the SCORE trial (2005) (0)
Long-term effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement: 3-year results of the TROPICAL study (2006) (0)
OUTCOME OF TRANSCATHETER AORTIC VALVE IMPLANTATION IN OCTOGENARIANS IN COMPARISON TO YOUNGER PATIENTS: RESULTS OF THE GERMAN REGISTRY ON TRANSCATHETER AORTIC VALVE IMPLANTATIONS (2010) (0)
P3723Impact of frailty status on 30-day mortality in patients with valvular heart disease undergoing percutaneous transcatheter valve interventions (2019) (0)
Simplify TAVR?: To Pre-Dilate, or Not to Pre-Dilate, That Is the Question. (2020) (0)
Why not "Simplify" TAVI? (2012) (0)
Peripheral perfusion of lower limb after transcatheter aortic valve implantation (TAVI) in patients with peripheral artery disease. (2019) (0)
1139-60 An intravascular ultrasound analysis from FUTURE I, the first human experience using everolimus-eluting stents: Six- and 12-month results (2004) (0)
PTA of a renal artery stenosis with a new embolization protection device: Evidence of side-branch occlusion due to distal embolization — A case report (2011) (0)
[Therapy of supraventricular reentry tachycardia by implantation of a demand-regulated overdrive pacemaker]. (1977) (0)
Intolerance of TEE probe Pulmonary complications Bronchospasm Hypoxia Cardiac complications Nonsustained ventricular tachycardia Transient atrial fibrillation Third-degree atrioventricular block Severe angina pectoris Bleeding complications Minor pharyngeal bleeding (2005) (0)
Transcatheter Aortic Valve Replacement in Patients at High Risk of Coronary Obstruction (2022) (0)
Impact of transradial versus transfemoral access for preprocedural coronary angiography on TAVR-associated complications (2023) (0)
Clinical outcomes in treatment of chronic total occlusions with the XIENCE V everolimus-eluting stent system in real-world patients: one-year pooled results from the XIENCE V USA and SPIRIT V studies (2013) (0)
Percutaneous transluminal aortic valve replacement: The CoreValve prosthesis (2010) (0)
Abstract 2640: Long-Term Clinical Follow-up of Patients with De Novo Coronary Bifurcation Lesions Treated with the Nitinol Self-Expanding Biolimus A9-Eluting "AXXESS" Stent - Results from the Prospective, Multicenter Axxess Plus Trial (2006) (0)
[Significance of microproteinuria for early detection of hypertension-induced end organ damage]. (1990) (0)
Abstract 4434: 12 Months and Beyond: Long-Term Results of the Direct Flow Medical Repositionable and Retrievable Pericardial Valve for Percutaneous Aortic Valve Replacement (2009) (0)
Impact of Device Landing Zone Calcification in Transcatheter Aortic Valve Implantation – The Device Landing Zone Calcification Score (2010) (0)
Dangas bivalirudin heparin TAVR BRAVO 3 appendix JACC 12 2015 (2015) (0)
Abstract 2833: Safety and Efficacy of Multiple, Overlapping Polymer-Based Paclitaxel-eluting Stents (2006) (0)
Everolimus-eluting stents (2005) (0)
The Use of Two-dimensional Sector Echocardiography in the Diagnosis of Coronary Heart Disease (1980) (0)
Renal function after transcatheter aortic valve implantation (2013) (0)
TRANSCATHETER AORTIC VALVE IMPLANTATION IN PATIENTS WITH BICUSPID AORTIC VALVE STENOSIS UTILIZING THE NEXT GENERATION FULLY RETRIEVABLE AND REPOSITIONABLE VALVE SYSTEM: EARLY RESULTS FROM THE MULTICENTER POL-TAVI REGISTRY (2017) (0)
The Sideguard Side Branch Stent (2012) (0)
Combined transcatheter aortic valve replacement and left atrial appendage occlusion in patients ineligible for oral anticoagulation: A case series. (2022) (0)
Guidant deliver II study: prospective, nonrandomized, multicenter evaluation o fthe ACHIEVE™ paclitaxel-eluting coronary stent system in the treatment of lesions with high risk of revascularization due to restenosis (2005) (0)
TCT-141 C-Reactive Protein/Albumin Ratio in Patients Undergoing Transcatheter Aortic Valve Replacement (2019) (0)
[Intra-aortic adverse pulsation]. (1978) (0)
Next generation of drug eluting stents'Sirolimus-analogues'. (2005) (0)
[Cardiomyopathy in progressive muscular dystrophy]. (1990) (0)
Paclitaxel Incorporated in a Slow-Release Polymer Formulation TAXUS III Trial : In-Stent Restenosis Treated With Stent-Based Delivery of (2003) (0)
[Computer tomographic diagnosis of pericardial effusions (author's transl)]. (1979) (0)
Intravascular ultrasound analysis of sirolimus-eluting stents for the treatment of in-stent restenosis: Results from the TROPICAL trial (2005) (0)
Gut Microbiota Signature in Heart Failure Defined From€Profiling of 2€Independent Cohorts (2018) (0)
P748Cardiac biomarkers and clinical scores for risk stratification in patients with severe symptomatic aortic stenosis undergoing TAVI. Which ranks first now (2017) (0)
Decoy for Prevention of Early Atherosclerosis in Coronary Bypass Vein Grafts: A Volumetric IVUS Subanalysis From a Prospective Randomized Double Blind Clinical Trial (2016) (0)
Abstract 13839: Systemic Inflammatory Response Syndrome Predicts Increased Mortality in Patients After Transcatheter Aortic Valve Implantation (2011) (0)
Coronary interventions in the elderly--the German ALKK Study Group experience. (2001) (0)
Abstract 3251: Long-Term Outcomes Following Treatment of In-Stent Restenosis with Drug-Eluting Stents: Insights from the TAXUS Meta-Analysis (2006) (0)
A novel approach to aortocoronary saphenous venous graft percutaneous treatment (2011) (0)
Impact of Transradial Versus Transfemoral Artery Approach for Pre-Procedural Coronary Angiography on Outcomes in Patients Undergoing Subsequent TAVR (2022) (0)
Percutaneous therapy for aortic valve disease (2010) (0)
Initial experiences with paclitaxel-eluting stents for treatment of de novo as well as in-stent restenotic lesions: TAXUS I and TAXUS III (2005) (0)
[30-day mortality after heart surgery: a pilot project of the Working Party of Directors of Hospital Cardiology Departments]. (2008) (0)
Retrograde endovascular aortic valve replacement: Initial experiences with the CoreValve® prosthesis (2006) (0)
[Determination of the examination planes in two-dimensional sector echocardiography (author's transl)]. (1979) (0)
Percutaneous Mitral Annuloplasty for Treatment of Functional Mitral Regurgitation (2009) (0)
Abstract 13258: 3d Speckle Tracking Analysis of Left Ventricular Function after Transcatheter Aortic Valve Implantation (2012) (0)
Consideration of the feasibility of transcatheter aortic valve implantation using cardiac computed tomography – Case report of a patient with severe aortic stenosis and undiagnosed coronary anomaly (2010) (0)
ong-Term Impact of Routinely Detected arly and Late Incomplete Stent Apposition (0)
[Cardiac effects of isoproterenol in the complex echocardiographic evaluation (author's transl)]. (1980) (0)
P6345Systemic inflammatory response syndrome following TAVI: what role do next generation transcatheter heart valves (THVs) play? (2017) (0)
[Comparison between i.a. DSA and cineangiography for evaluating the coronary arteries and the left ventricle]. (1986) (0)
The renal resistance index for the non-invasive assessment of paravalvular aortic regurgitation after transcatheter aortic valve implantation (2013) (0)
VESSEL RESPONSE TO THE NOVEL POLYMER-FREE BIOFREEDOM STENT VERSUS CONVENTIONAL DURABLE POLYMER COATING STENT: SHORT- AND MID-TERM INTRAVASCULAR ULTRASOUND RESULTS FROM THE BIOFREEDOM FIRST-IN-MAN TRIAL (2011) (0)
TCT-872 Results of transfemoral TAVI in Partner-like Patients – A comparison with Real-World Patients (2012) (0)
[Coronary spasms in selective coronary angiography]. (1979) (0)
Advancing the Delivery System Across the Aorta and Valve (CoreValve) (2009) (0)
P749Peri-procedural myocardial injury depends on transcatheter heart valve type but does not predict mortality in patients after tavi (2017) (0)
TCT-692 The effect of balloon predilatation in TAVI on long-term mortality (2015) (0)
[Motion analysis of the left ventricle by two dimensional sector echokardiography (author's transl)]. (1978) (0)
TCT-730 Long-term performance of a transfemorally implantable nonmetallic, retrievable and repositionable aortic valve in patients with severe aortic stenosis- 5 Year Follow-Up of the 22 F-Direct Flow Medical Valve (2014) (0)
TCT-772 The Effect of Appropriate Implant Position for the Evolut R Self-Expanding Transcatheter Aortic Valve: Analysis from the FORWARD Study (2017) (0)
Abstract 12656: The Impact of Periprosthetic Aortic Regurgitation on Outcome in Patients After Transcatheter Aortic Valve Implantation (2011) (0)
[Malignant fibrous mesothelioma of the pericardium]. (1981) (0)
INCIDENCE, PREDICTORS AND IMPACT OF MAJOR BLEEDING IN PATIENTS UNDERGOING TRANSFEMORAL TRANSCATHETER AORTIC VALVE REPLACEMENT WITH BIVALIRUDIN OR UNFRACTIONATED HEPARIN: FROM THE EFFECT OF BIVALIRUDIN ON AORTIC VALVE INTERVENTION OUTCOMES (BRAVO) TRIAL (2016) (0)
2 Glomerular hyperfiltration in essential hypertension: correlation with hypertensive heart disease (1988) (0)
Nine-month results of the TROPICAL study: a multicenter nonrandomized study of the Cypher((TM)) sirolimus-eluting stent in the treatment of patients with an instent restenotic native coronary artery lesion (2004) (0)
Saphenous vein grafts and arterial conduits (2007) (0)
Predictive value of the Fibrosis-4 index in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement (2022) (0)
PRELIMINARY ANGIOGRAPHIC RESULTS OF THE NOVEL POLYMER-FREE BIOLIMUS-A9 COATED STENTS FOR THE TREATMENT OF CORONARY ARTERY LESIONS - FOUR-MONTH ANGIOGRAPHIC FOLLOW-UP OF THE PROSPECTIVE, RANDOMIZED, MULTICENTER BIOFREEDOM TRIAL (2010) (0)
[Computer-cardio-tomography in idiopathic hypertrophic subvalvular aortic stenosis--a new contribution to non-invasive diagnosis (author's transl)]. (1979) (0)
[Heart involvement in progressive systemic sclerosis (generalized scleroderma)]. (1984) (0)
Influence of calcium on neointimal growth following drug-eluting and bare metal stents implantation: A 3-D intravascular ultrasound substudy of the SCORE trial (2003) (0)
[Embolism prevention during interventional treatment of aortocoronary bypass stenoses]. (2001) (0)
CRT-707 The Impact of Acute and Chronic Troponin Elevation After Transcatheter Aortic Valve Implantation (2014) (0)
P6403Impact of hemodynamic support on outcome in patients undergoing high-risk percutaneous coronary intervention (2018) (0)
TCT-674 Implication of peri-procedural biomarker elevation after stent implantation: analysis from the pooled XIENCE V trials (2012) (0)
Drug-Eluting Stents Current clinical experience and future directions (0)
New journal for the interventional cardiology community (2009) (0)
[Comparative postoperative studies following implantation of synthetic and xenograft prosthesis in the mitral position. An echocardiographic study]. (1977) (0)
Abstract 2774: Six-Month IVUS Analysis of Long Coronary Artery Lesions Treated with Biolimus-A9 Eluting XTENT interdigitating stent with bioabsorbable polymer: Results of the CUSTOM II Trial (2007) (0)
Directional atherectomy for treatment of stent restenosis — feasibility and histopathological findings in 28 patients (1998) (0)
TCT-594 Five year and Final Report of BioFreedom First-In-Man, a Randomized Trial comparing Polymer-Free BioFreedom™ stents with Durable Polymer Taxus Liberté™ Stents (2014) (0)
[The value of antitachycardia pacemaker therapy in patients with Wolff-Parkinson-White syndrome]. (1983) (0)
DEGREE AND DISTRIBUTION OF AORTIC ANNULUS CALCIFICATION AS A PREDICTIVE FACTOR FOR PACEMAKER IMPLANTATION AFTER COREVALVE TAVI. A CT DRIVEN, PROSPECTIVE, SINGLE-CENTER STUDY (2010) (0)
Association of heart failure duration with clinical outcomes after transcatheter mitral valve repair for functional mitral regurgitation (2020) (0)
Microstent to GFX: Experience in 2,325 Patients (1998) (0)
[Echocardiographic contrast studies for the delineation of the heart cavities using peripheral venous sodium chloride injections. A contribution to shunt diagnosis]. (1977) (0)
ECG in Atrial and Ventricular Arrhythmias Abstract 1741 : Predicting Coronary Stenosis by Computer-Enhanced , Resting Electrocardiogram : Effect of Gender , Age , and Revascularization on Sensitivity and Specificity (2007) (0)
TCT-771 30-Day Outcomes in Patients with a Society of Thoracic Surgeons Predicted Risk of Mortality <3% from the Evolut R FORWARD Study (2017) (0)
Abstract 13910: The Impact of Peripheral Arterial Disease on Early Outcome After Transcatheter Aortic Valve Implantation. Results From the German TAVI Registry. (2011) (0)
2648 – EFFECT OF INTRAVENOUS QUINIDINE ON LEFT VENTRICULAR PERFORMANCE (1978) (0)
NONPOLYMER-BASED BIOLIMUS-ELUTING STENT ACCELERATES OVERALL NEOINTIMAL COVERAGE: SHORT- AND MID-TERM INTRAVASCULAR ULTRASOUND RESULTS FROM STEALTH AND BIOFREEDOM TRIALS (2011) (0)
[Quantitative regional functional analysis of the left ventricle using ECG-directed cardiac computerized tomography]. (1987) (0)
Catch me, if you can! (2012) (0)
Incidence and Predictors of Drug-Eluting Stent Thrombosis During and After Discontinuation of Thienopyridine Treatment Interventional Cardiology (2007) (0)
High‐Frequency Mechanical Revascularization (2013) (0)
2293 – EVALUATION OF ECHOCARDIOGRAPHIC PARAMETERS IN CORRELATION TO PLASMA LEVELS OF PROPRANOLOL (1978) (0)
Why we should never return to bare metal stents? (2008) (0)
Is the Quantification of Mitral Stenosis and Aortic Stenosis by Transesophageal Echocardiography Feasible (1989) (0)
Paclitaxel-eluting coronary stent implantation in calcified coronary lesions (2006) (0)
Percutaneous aortic valve implantation – an experience with the LotusTM repositionable device (2015) (0)
[Surgical or interventional aortic valve repair? Pro interventional repair]. (2008) (0)
Percutaneous Implantation of Aortic Valvular Prosthesis (Self‐Expanded Prosthesis) (2009) (0)
VERY LONG-TERM SERIAL INTRAVASCULAR ULTRASOUND EVALUATION OF BIOLIMUSA9-ELUTING STENT WITH BIODEGRADABLE POLYMER (2011) (0)
Tacrolimus eluting stents (2005) (0)
[Paroxysmal tachycardic atrial fibrillation: termination by surgically induced A-V block (author's transl)]. (1975) (0)
MANAGEMENT OF PARAVALVULAR AORTIC REGURGITATION AFTER TAVR: PROSPECTIVE EVALUATION OF THE AORTIC REGURGITATION INDEX (2013) (0)
[Intermittent intra-aortic counterpulsation as therapy in threatening and manifest heart failure]. (1976) (0)
CRT-200.54 Evaluation of 2-year Clinical Outcomes From Post-market Trials With Everolimus-eluting Cobalt Chromium Stents in Diabetics (2016) (0)
Abstract 4498: Role of Self-Expanding Drug-Eluting Axxess Stent in Bifurcation Lesions: Intravascular Ultrasound Findings of AXXESS, AXXENT and DIVERGE Trials (2008) (0)
IMPACT OF CHRONIC KIDNEY DISEASE ON OUTCOMES IN PATIENTS UNDERGOING TRANSFEMORAL TRANSCATHETER AORTIC VALVE REPLACEMENT WITH BIVALIRUDIN OR UNFRACTIONATED HEPARIN: FROM THE EFFECT OF BIVALIRUDIN ON AORTIC VALVE INTERVENTION OUTCOMES (BRAVO) TRIAL (2016) (0)
ACUTE AND MID-TERM RESULTS FROM A FIM/APPROVAL TRIAL OF A 2ND GENERATION TRANSFEMORAL AORTIC BIOPROSTHESIS FOR THE TREATMENT OF PATIENTS WITH SEVERE AORTIC STENOSIS (2014) (0)
[2-dimensional sector echocardiography]. (1979) (0)
Predilation in Transcatheter Aortic Valve Implantation (2019) (0)
An update on the current state of the CoreValve device (2008) (0)
Symptom Control and Psychosocial Rehabilitation of Chronic Pacemaker Patients with Different Pacing Modes (1983) (0)
TCT-813 Long-term performance of a transfemorally implantable nonmetallic, retrievable and repositionable aortic valve in patients with severe aortic stenosis 4 Year Follow-Up of the 22 F-Direct Flow Medical Valve (2012) (0)
Emerging Technologies: Stents (2008) (0)
Abstract 13245: Three-Dimensional Imaging of Aortic Valve Geometry Prior to Tavi Procedures: Comparison Between 3d-Transesophageal Echocardiography and Contrast Enhanced Computed Tomography (2012) (0)
IS THERE A DIFFERENCE IN VASCULAR RESPONSE BETWEEN BIODEGRADABLE POLYMER-BASED VERSUS NONPOLYMER-BASED BIOLIMUS-ELUTING STENT? SHORT-TERM INTRAVASCULAR ULTRASOUND RESULTS FROM STEALTH AND BIOFREEDOM TRIAL (2010) (0)
[Indoramin in severe cardiac insufficiency. Acute hemodynamic effectiveness]. (2008) (0)
S44-1 PERCUTANEOUS AORTIC VALVE DEPLOYMENT (2007) (0)
TCT-763 A Risk Prediction Algorithm for 1-Year Mortality after Transcatheter Aortic Valve Implantation (2013) (0)
P6034Prognostic value of logistic EuroSCORE and STS-PROM in a recent patient cohort undergoing TAVI with next generation transcatheter heart valves (2018) (0)
Abstract 1976: Angiographic versus Intravascular Ultrasound Parameters of Drug-Eluting Stent Efficacy: A Meta-Analysis from TAXUS IV, V and VI (2006) (0)
Abstract 3791: Experience with 21 French Percutaneous CoreValve Aortic Valve Replacement in Patients Unsuitable for Surgical Aortic Valve Replacement (2006) (0)
Automatic and Interactive Image Processing of 2-D Echocardiogramms for Analysis of Left Ventricular Function (1982) (0)
Percutaneous theapy for aortic valve disease (2010) (0)
Abstract 3389: Percutaneous Aortic Valve Replacement with a self expandable bioprosthesis: Early and Intermediate Echocardiographic Follow-up (2007) (0)
COMPUTERIZED RESTING ECG ANALYSIS FOR THE DETECTION OF CORONARY ARTERY STENOSIS AFTER CORONARY REVASCULARIZATION IN COMPARISON WITH ANGIOGRAPHIC FINDINGS (2007) (0)
EFFECT OF BIVALIRUDIN VERSUS HEPARIN IN A CONTEMPORARY TAVR POPULATION OF WOMEN: RESULTS FROM THE BRAVO 3 RANDOMIZED TRIAL (2016) (0)
Impact of Pulmonary Hypertension on Outcome after Transcatheter Aortic Valve Implantation (2012) (0)
Unbreak My Heart (Valve) (2017) (0)
Combined percutaneous treatment of structural and congenital heart defects: more than just a feasible procedure in the catheterization laboratory (2015) (0)
State-of-the-art TAVI - how much minimalism is enough? (2019) (0)
Intraoperative Gene Therapy of Coronary Artery Bypass Vein Grafts with E2F-Decoy: A Volumetric IVUS Subanalysis from PREVENT II Study (2003) (0)
[Significance of propranolol action on the AH-time for the diagnosis of normal and aberrant atrial-His correlations]. (1977) (0)
P3417Reclassification into moderate aortic valve stenosis after hybrid continuity equation by combination of CT and echocardiography and its clinical impact (2018) (0)
1101-44 Effect of everolimus-eluting stents in preventing neointimal hyperplasia: An intravascular ultrasound analysis from the FUTURE II trial (2004) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Eberhardt Grube?

Eberhardt Grube is affiliated with the following schools:

Eberhardt Grube's Academic­Influence.com Rankings

Eberhardt Grube's Degrees

Why Is Eberhardt Grube Influential?

Eberhardt Grube's Published Works

Published Works

What Schools Are Affiliated With Eberhardt Grube?

Eberhardt Grube's AcademicInfluence.com Rankings